CRINONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Crinone, and when can generic versions of Crinone launch?
Crinone is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in CRINONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Crinone
A generic version of CRINONE was approved as progesterone by FRESENIUS KABI USA on April 25th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CRINONE?
- What are the global sales for CRINONE?
- What is Average Wholesale Price for CRINONE?
Summary for CRINONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 23 |
Patent Applications: | 5,415 |
Drug Prices: | Drug price information for CRINONE |
What excipients (inactive ingredients) are in CRINONE? | CRINONE excipients list |
DailyMed Link: | CRINONE at DailyMed |
Recent Clinical Trials for CRINONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
IBSA Institut Biochimique SA | Phase 3 |
Merck Serono Co., Ltd., Beijing, China | Phase 4 |
Merck Serono Co., Ltd. | Phase 4 |
Pharmacology for CRINONE
Drug Class | Progesterone |
US Patents and Regulatory Information for CRINONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-001 | Jul 31, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-002 | Jul 31, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CRINONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-001 | Jul 31, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-002 | Jul 31, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-002 | Jul 31, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | CRINONE | progesterone | GEL;VAGINAL | 020701-001 | Jul 31, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CRINONE
See the table below for patents covering CRINONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0163696 | USE OF A BIOADHESIVE | ⤷ Sign Up |
Lithuania | 96027 | ⤷ Sign Up | |
Lithuania | 4072 | USE OF A CROSS-LINKED POLYCARBOXYLIC POLYMER AND PROGESTERONE FOR MANUFACTURE OF MEDICINAL PREPARATIONS | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 9507699 | ⤷ Sign Up | |
Norway | 961044 | ⤷ Sign Up | |
Latvia | 11527 | NOVEL METHOD OF USE OF PROGESTERONE | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CRINONE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2782584 | 21C1058 | France | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), Y COMPRIS SOUS FORME HEMIHYDRATEE, ET DE LA PROGESTERONE; NAT. REGISTRATION NO/DATE: NL51886 20210421; FIRST REGISTRATION: BE - BE582231 20210406 |
2782584 | 301153 | Netherlands | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406 |
2782584 | 2021C/558 | Belgium | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17--ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
2782584 | LUC00245 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (Y COMPRIS SOUS FORME HEMIHYDRATEE), ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210701 |
0113964 | 97C0037 | Belgium | ⤷ Sign Up | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
2861072 | 2024C/512 | Belgium | ⤷ Sign Up | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL, EVENTUELLEMENT SOUS FORME D'UN SEL, HYDRATE OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE (Y COMPRIS SOUS FORME HEMIHYDRATEE) ET DE LA PROGESTERONE; AUTHORISATION NUMBER AND DATE: BE582231 20210406 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |